153 related articles for article (PubMed ID: 2110131)
1. Analysis of clonal evolution in a tumor consisting of pSV2neo-transfected mouse fibrosarcoma clones.
Enoki Y; Niwa O; Yokoro K; Toge T
Jpn J Cancer Res; 1990 Feb; 81(2):141-7. PubMed ID: 2110131
[TBL] [Abstract][Full Text] [Related]
2. Random process of metastasis and generation of heterogeneity in a mouse sarcoma line.
Niwa O; Enoki Y; Sadamoto S; Kamiya K; Yokoro K
Jpn J Cancer Res; 1993 Jan; 84(1):42-7. PubMed ID: 8449827
[TBL] [Abstract][Full Text] [Related]
3. Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
Mialdea MJ; Martin J; Gaforio JJ; Algarra I; Pérez M; Gonzalez A; Ljunggren HG; Garrido F
Int J Cancer; 1992 Aug; 52(1):153-8. PubMed ID: 1500219
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F
Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185
[TBL] [Abstract][Full Text] [Related]
5. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
Mahalingam M; Ugen KE; Kao KJ; Klein PA
Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
[TBL] [Abstract][Full Text] [Related]
6. Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker.
Moffett BF; Baban D; Bao L; Tarin D
Cancer Res; 1992 Apr; 52(7):1737-43. PubMed ID: 1551102
[TBL] [Abstract][Full Text] [Related]
7. Clonal selection within metastatic SP1 mouse mammary tumors is independent of metastatic potential.
Samiei M; Waghorne CG
Int J Cancer; 1991 Mar; 47(5):771-5. PubMed ID: 2004857
[TBL] [Abstract][Full Text] [Related]
8. Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma.
Wang N; Yu SH; Liener IE; Hebbel RP; Eaton JW; McKhann CF
Cancer Res; 1982 Mar; 42(3):1046-51. PubMed ID: 6174210
[TBL] [Abstract][Full Text] [Related]
9. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
10. The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice.
Price JE; Bell C; Frost P
Int J Cancer; 1990 May; 45(5):968-71. PubMed ID: 2159442
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of tumorigenicity phenotype in murine tumors. Characterization of tumor clones isolated from primary 3-methylcholanthrene-induced fibrosarcomas.
Schmitt M; Daynes RA
Transplantation; 1982 Apr; 33(4):387-92. PubMed ID: 6176054
[TBL] [Abstract][Full Text] [Related]
12. The effect of immunity on pulmonary metastasis of a methylcholanthrene-induced fibrosarcoma and three of its clones.
Yu S; Wang N; McKhann CF
J Surg Oncol; 1984 Sep; 27(1):51-8. PubMed ID: 6482454
[TBL] [Abstract][Full Text] [Related]
13. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas.
Ogata M; Shimizu J; Kosaka H; Maekawa R; Shimizu K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Nov; 77(11):1134-41. PubMed ID: 3098723
[TBL] [Abstract][Full Text] [Related]
14. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
15. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
Pérez M; Algarra I; Ljunggren HG; Caballero A; Mialdea MJ; Gaforio JJ; Klein G; Kärre K; Garrido F
Int J Cancer; 1990 Aug; 46(2):258-61. PubMed ID: 2116997
[TBL] [Abstract][Full Text] [Related]
16. The use of molecular genetic markers to demonstrate the effect of organ environment on clonal dominance in a human renal-cell carcinoma grown in nude mice.
Staroselsky AN; Radinsky R; Fidler IJ; Pathak S; Chernajovsky Y; Frost P
Int J Cancer; 1992 Apr; 51(1):130-8. PubMed ID: 1563832
[TBL] [Abstract][Full Text] [Related]
17. Reversible changes in tumor growth and metastatic behavior induced by immune pressure.
Yu S; McKhann CF; Flye MW
Surgery; 1990 Jan; 107(1):28-35. PubMed ID: 2296755
[TBL] [Abstract][Full Text] [Related]
18. Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo.
Korczak B; Robson IB; Lamarche C; Bernstein A; Kerbel RS
Mol Cell Biol; 1988 Aug; 8(8):3143-9. PubMed ID: 3211140
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic heterogeneity of genetically marked and metastatically competent "dominant" tumor cell clones.
Bell C; Frost P; Kerbel RS
Cancer Genet Cytogenet; 1991 Jul; 54(2):153-61. PubMed ID: 1884347
[TBL] [Abstract][Full Text] [Related]
20. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
